What Happened: The Dogecoin Foundation, a nonprofit organization aiming to support the development of the Dogecoin (CRYPTO: DOGE) ecosystem, is planning to open its headquarters in Liechtenstein.
The core team of the Foundation, which includes Ethereum (CRYPTO: ETH) co-founder Vitalik Buterin and Tesla Inc (NASDAQ:TSLA) CEO Elon Musk's legal and financial advisor Jared Birchall, told Decrypt.
Other key members of the Foundation are Ross Nicoll, Michi Lumin, Timothy Stebbing, Gary Lachance, and Jens Wiechers.
“We are currently in talks with people in Liechtenstein to establish a long-term legal entity there,” said board member Jens Wiechers.
“Liechtenstein has remained incredibly crypto-friendly, and as a member of the European Economic Area (EEA) would give the Foundation flexibility to operate with other European organizations,” Wiechers added.
“The foundation serves as an embodiment of Dogecoin to allow advocacy, support, and defense of Dogecoin to occur,” Foundation board member Michi Lumens told Decrypt.
Top 10 Stocks To Buy Right Now: Brown(n)
N Brown Group plc operates as an Internet and catalogue home shopping company in the United Kingdom. The company principally offers womenswear, menswear, footwear, household, and electrical products, as well as provides insurance services. It also operates in the Republic of Ireland, Germany, and the United States. The company was founded in 1859 and is based in Manchester, the United Kingdom.
Advisors’ Opinion:
- [By Max Byerly]
Media stories about NetSuite (NYSE:N) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. NetSuite earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned news articles about the technology company an impact score of 45.0110873191596 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Top 10 Stocks To Buy Right Now: Pinnacle West Capital Corporation(PNW)
Pinnacle West Capital Corporation, through its subsidiaries, provides retail and wholesale electric services primarily in the State of Arizona. The company involves in the generation, transmission, and distribution of electricity through coal, nuclear, gas and oil, and solar resources. It also offers energy-related products and services, such as energy master planning, energy use consultation and facility audits, cogeneration analysis and installation, and project management with a focus on energy efficiency and renewable energy to commercial and industrial retail customers in the western United States. In addition, the company owns minority interests in various energy-related investments and Arizona community-based ventures; and develops residential, commercial, and industrial real estate projects in Arizona, Idaho, New Mexico, and Utah. As of December 31, 2010, it owned or leased approximately 6,290 mega watts of regulated generation capacity; and serviced approximately 1.1 million customers. Pinnacle West Capital Corporation was founded in 1920 and is based in Phoenix, Arizona.
Advisors’ Opinion:
- [By Motley Fool Transcribers]
Pinnacle West Capital Corp (NYSE:PNW)Q42018 Earnings Conference CallFeb. 22, 2019, 11:00 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Joseph Griffin]
Pinnacle West Capital (NYSE:PNW) last posted its quarterly earnings results on Friday, August 3rd. The utilities provider reported $1.48 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.44 by $0.04. The firm had revenue of $974.12 million during the quarter, compared to analysts’ expectations of $939.59 million. Pinnacle West Capital had a return on equity of 9.12% and a net margin of 12.95%. The company’s revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.49 earnings per share. analysts anticipate that Pinnacle West Capital Co. will post 4.45 earnings per share for the current year.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Pinnacle West Capital (PNW)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Russell Investments Group Ltd. lowered its stake in shares of Pinnacle West Capital Co. (NYSE:PNW) by 15.5% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 148,258 shares of the utilities provider’s stock after selling 27,229 shares during the period. Russell Investments Group Ltd. owned about 0.13% of Pinnacle West Capital worth $11,945,000 at the end of the most recent quarter.
Top 10 Stocks To Buy Right Now: Square, Inc.(SQ)
Square, Inc. develops and provides point-of-sale software worldwide. It provides Square Register, a point-of-sale system that takes care of digital receipts, inventory, and sales reports, as well as provides analytics and feedback. The company serves big and small businesses from bakeries to retailers. Its product, Square Register, is available in the App Store and on Google Play, and it is designed to run on a smartphone or tablet, and on counter. Square, Inc. is headquartered in San Francisco, California.
Advisors’ Opinion:
- [By Shane Hupp]
ILLEGAL ACTIVITY NOTICE: “BB&T Securities LLC Acquires 1,782 Shares of FirstService Corp (FSV)” was originally published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at www.tickerreport.com/banking-finance/4158310/bbt-securities-llc-acquires-1782-shares-of-firstservice-corp-fsv.html.
- [By Stephan Byrd]
ILLEGAL ACTIVITY NOTICE: “FirstService (FSV) Set to Announce Quarterly Earnings on Wednesday” was first published by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at www.tickerreport.com/banking-finance/4123840/firstservice-fsv-set-to-announce-quarterly-earnings-on-wednesday.html.
- [By Max Byerly]
Gazit Globe (NYSE:GZT) and FirstService (NASDAQ:FSV) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation.
Top 10 Stocks To Buy Right Now: Vanda Pharmaceuticals Inc.(VNDA)
Vanda Pharmaceuticals Inc., incorporated on November 13, 2002, is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of central nervous system (CNS) disorders. The Company’s product portfolio includes HETLIOZ (tasimelteon), Fanapt (iloperidone), Tradipitant (VLY-686), Trichostatin A and AQW051.
HETLIOZ
The Company offers HETLIOZ (tasimelteon) for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24). HETLIOZ is a melatonin agonist of the human MT1 and MT2 receptors, with specificity for MT2. HETLIOZ has utility in a range of circadian rhythm disorders, and is in in clinical development for the treatment of Jet Lag Disorder and Smith-Magenis Syndrome (SMS).
Fanapt
The Company offers Fanapt (iloperidone) for the treatment of schizophrenia. Additionally, its distribution partners launched Fanapt in Israel and Mexico.
Tradipitant
Tradipitant (VLY-686) is a small molecule neurokinin-1 receptor (NK-1R) antagonist, which is in clinical development for the treatment of chronic pruritus in atopic dermatitis. NK-1R antagonists have been evaluated in a range of indications, including chemotherapy-induced nausea and vomiting (CINV), post-operative nausea and vomiting (PONV), alcohol dependence, anxiety, depression and pruritus.
Trichostatin A
Trichostatin A is a small molecule histone deacetylase (HDAC) inhibitor. It has a potential use as a treatment for several oncology indications.
AQW051
AQW051 is a Phase II alpha-7 nicotinic acetylcholine receptor partial agonist. It is indicated for the treatment of CNS Disorders.
The Company competes with Takeda Pharmaceuticals Company Limited, Sanofi, Sunovion Pharmaceuticals Inc., Pfizer Inc., Pernix Therapeutics, Merck & Co., Inc., Servier, Neurim Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Ortho-McNeil-Janssen Pharmaceuticals, In! c., Eli Lilly and Company, AstraZeneca PLC, BMS/Otsuka America Pharmaceutical Inc., Lundbeck/Otsuka America Pharmaceutical Inc., Actavis plc, Otsuka Pharmaceutical, Inc. and Alkermes, Inc.
Advisors’ Opinion:
- [By Stephan Byrd]
ValuEngine lowered shares of Vanda Pharmaceuticals (NASDAQ:VNDA) from a buy rating to a hold rating in a report issued on Saturday.
Several other brokerages have also commented on VNDA. Oppenheimer dropped their price target on shares of Vanda Pharmaceuticals from $29.00 to $21.00 in a research report on Thursday, February 14th. Jefferies Financial Group upped their price target on shares of Vanda Pharmaceuticals from $30.00 to $40.00 and gave the stock a buy rating in a research report on Tuesday, December 4th. Cantor Fitzgerald raised shares of Vanda Pharmaceuticals from a neutral rating to an overweight rating and set a $43.00 price target for the company in a research report on Tuesday, December 4th. Citigroup upped their price target on shares of Vanda Pharmaceuticals from $31.00 to $47.00 and gave the stock a buy rating in a research report on Friday, December 7th. Finally, CIBC reaffirmed a market perform rating on shares of Vanda Pharmaceuticals in a research report on Tuesday, December 11th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of Hold and an average target price of $34.75.
- [By Joseph Griffin]
Vanda Pharmaceuticals (NASDAQ:VNDA) last posted its quarterly earnings data on Wednesday, February 13th. The biopharmaceutical company reported $0.19 EPS for the quarter, beating the consensus estimate of ($0.03) by $0.22. Vanda Pharmaceuticals had a return on equity of 9.80% and a net margin of 13.05%. The business had revenue of $53.04 million for the quarter, compared to the consensus estimate of $51.56 million. During the same quarter in the prior year, the business earned ($0.04) earnings per share. Vanda Pharmaceuticals’s revenue for the quarter was up 19.8% on a year-over-year basis. Equities analysts anticipate that Vanda Pharmaceuticals Inc. will post 0.22 earnings per share for the current year.
Top 10 Stocks To Buy Right Now: Oceaneering International, Inc.(OII)
Oceaneering International, Inc. is a global oilfield provider of engineered services and products, primarily to the offshore oil and gas industry, with a focus on deepwater applications. Oceaneering also serves the defense, aerospace and commercial theme park industries. Oceaneering was organized as a Delaware corporation in 1969 out of the combination of three diving service companies founded in the early 1960s. Since our establishment, we have concentrated on the development and marketing of underwater services and products to meet customer needs requiring the use of advanced deepwater technology. We believe we are one of the world’s largest underwater services contractors. Advisors’ Opinion:
- [By Logan Wallace]
Eaton Vance Management lessened its holdings in Oceaneering International (NYSE:OII) by 44.5% during the fourth quarter, Holdings Channel reports. The fund owned 1,376,354 shares of the oil and gas company’s stock after selling 1,104,665 shares during the period. Eaton Vance Management’s holdings in Oceaneering International were worth $16,653,000 at the end of the most recent reporting period.
- [By Shane Hupp]
Shares of Oceaneering International (NYSE:OII) have been given a consensus recommendation of “Hold” by the eighteen ratings firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and three have given a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $22.75.
- [By Motley Fool Transcribing]
Oceaneering International (NYSE:OII) Q4 2018 Earnings Conference CallFeb. 14, 2019 11:00 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
Top 10 Stocks To Buy Right Now: Hill-Rom Holdings Inc(HRC)
Hill-Rom Holdings, Inc., incorporated on August 7, 1969, is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. The Company’s segments include North America, Surgical and Respiratory Care, International and Welch Allyn. The North America segment sells and rents its support and near-patient technologies and services, as well as clinical workflow solutions in the United States and Canada. The Surgical and Respiratory Care segment sells and rents its surgical and respiratory care products across the globe. The International segment sells and rents similar products as the Company’s North America segment in regions outside of the United States and Canada. The Welch Allyn segment sells medical diagnostic equipment and a portfolio of devices that assess, diagnose, treat and manage a range of illnesses and diseases across the globe.
The Company’s patient care systems include various bed systems, such as Medical Surgical (MedSurg) beds, Intensive Care Unit (ICU) beds, and Bariatric patient beds, as well as mobility solutions, such as lifts and other devices used to safely move patients. Its advanced patient care systems provide patient data reporting, patient safety alarms and caregiver alerts concerning such things as bed exit, bed height, patient positioning, point of care controls, patient turn assist and upright positioning. Supporting solutions within the patient/resident room include architectural products, such as headwalls, and healthcare furniture. It rents and sells non-invasive therapeutic products and surfaces designed for the prevention and treatment of various acute and chronic medical conditions, including pulmonary, wound and bariatric conditions. Its medical equipment management and contract services provide rentals and healthcare provider asset management services for various moveable med! ical equipment (MME), such as ventilators, defibrillators, intravenous pumps and patient monitoring equipment in its North America segment. In addition, the Company sells equipment service contracts for its capital equipment, primarily in the United States.
The Company develops and markets various communications technologies and software solutions. Its communications technologies and software solutions are designed to improve patient safety and efficiency at the point of care by, among other things, enabling patient-to-staff and staff-to-staff communications, aggregating and delivering patient data, tracking staff and assets, and monitoring hand hygiene compliance. The NaviCare Platform is used to support multiple clinical solutions and applications, including nurse call, asset tracking, staff and patient locating, and hand-hygiene monitoring. This product category also includes its Welch Allyn products. It offers surgical tables, lights and pendants utilized within the operating room setting. It also offers a range of positioning devices for use in shoulder, hip, spinal and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room table. In addition, it offers operating room surgical safety and accessory products, such as scalpel and blade, light handle systems, skin markers and other disposable products. The Company offers therapeutic products that provide bronchial hygiene (airway clearance) for acute and home care patients.
The Company’s products include The Vest Airway Clearance System, which is designed to assist patients in the mobilization of retained blockages; the VitalCough System, which is a non-invasive therapy that stimulates a cough to remove secretions in patients with compromised peak cough flow, and the MetaNeb Systems, which is a triple-therapy system indicated for the mobilization of secretions, lung expansion therapy and aerosol delivery.
The Company operates through a range of channels, including sales and ren! tals of p! roducts to acute and extended care facilities across the world through both a direct sales force and distributors; sales and rentals of products directly to patients in the home, and sales into primary care facilities. Through its network of approximately 160 North American and over 50 international service centers, and approximately 1,500 service professionals, the Company provides technical support and services, and delivers its products to customers on an as-needed basis.
The Company competes with Getinge AB, Guldmann, Invacare, Joerns Healthcare, Freedom Medical, Inc., Ascom Holding, Covidien, Ltd., Exergen Corporation, GE Healthcare, Heine Optotechnik, Action Medical, DeRoyal, Draeger, MizuhoOSI, Electromed, Inc., Philips, Respirtech, Linet, Stiegelmeyer, Stryker Corporation, SIZEWise Rentals, LLC, Universal Hospital Services, Inc., Omron Healthcare, Rauland-Borg Corporation, Riester, Skytron, Steris and Swann-Morton.
Advisors’ Opinion:
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Hill-Rom (HRC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Hill-Rom (NYSE:HRC) and Globus Medical (NYSE:GMED) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Hill-Rom (HRC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Get a free copy of the Zacks research report on Hill-Rom (HRC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Stocks To Buy Right Now: PCM, Inc.(PCMI)
PCM, Inc., incorporated on February 9, 1995, is engaged in providing technology products, services and solutions through direct marketing channels, and owned and operated data centers. The Company offers technology products, solutions and other consumer products. The Company’s segments include Commercial, Public Sector, MacMall, Canada, and Corporate & Other. The Company sells its products primarily to customers in the United States and Canada, and maintains offices throughout the United States and Canada, as well as in Montreal, Canada and Manila, Philippines.
The Company’s Commercial segment sells complex products, services and solutions to commercial businesses in the United States. It sells its products using multiple sales channels, including a field relationship-based selling model, an outbound phone-based sales force, a field services organization and an online extranet. The Company’s Public Sector segment consists of sales made primarily to federal, state and local governments, as well as educational institutions. The Public Sector segment utilizes a phone and field relationship-based selling model, as well as contract and bid business development teams and an online extranet. The Company’s MacMall segment consists of sales made through telephone and the Internet to consumers, small businesses and creative professionals. The Company’s systems are located in its data centers in El Segundo, California, Columbus, Ohio and Atlanta, Georgia. The Company’s Canada segment consists of sales made to customers in the Canadian market.
The Company competes with CDW, Insight Enterprises, PC Connection, CompuCom Systems, Pomeroy IT Solutions, World Wide Technology, CDWG, GovConnection, Best Buy, Office Depot, Staples, Apple, Hewlett Packard Enterprise, HP Inc., Dell, Amazon.com, Newegg.com, Soft Choice and Software House International.
Advisors’ Opinion:
- [By Max Byerly]
TheStreet upgraded shares of PCM (NASDAQ:PCMI) from a c rating to a b- rating in a report released on Wednesday.
PCMI has been the topic of several other reports. Roth Capital upped their price target on shares of PCM from $24.20 to $29.60 and gave the stock a buy rating in a research report on Thursday. B. Riley upped their price target on shares of PCM from $25.00 to $27.00 and gave the stock a buy rating in a research report on Thursday, October 25th. Zacks Investment Research raised shares of PCM from a hold rating to a buy rating and set a $19.00 price target on the stock in a research report on Wednesday, October 24th. ValuEngine lowered shares of PCM from a hold rating to a sell rating in a research report on Friday, December 21st. Finally, BidaskClub raised shares of PCM from a hold rating to a buy rating in a research report on Tuesday, January 29th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. The stock currently has an average rating of Buy and a consensus price target of $26.87.
- [By Motley Fool Transcribers]
PCM Inc (NASDAQ:PCMI)Q42018 Earnings Conference CallFeb. 06, 2019, 9:00 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
Top 10 Stocks To Buy Right Now: Clear Channel Outdoor Holdings, Inc.(CCO)
Clear Channel Outdoor Holdings, Inc., an outdoor advertising company, owns and operates advertising display faces worldwide. It operates in two segments, Americas and International. The company offers advertising services through billboards comprising bulletins and posters; street furniture displays, including advertising surfaces on bus shelters, information kiosks, freestanding units, and other public structures; transit displays, which are advertising surfaces on various types of vehicles or within transit systems; and other out-of-home advertising displays, such as wallscapes and spectaculars, as well as mall displays. It also operates SmartBike bicycle rental program, which provides bicycles for rent to the general public in various municipalities; and sells street furniture equipment, as well as provides cleaning and maintenance, and production and creative services. Clear Channel Outdoor Holdings, Inc. serves the retail, business services, media, healthcare and medical, banking and financial services, food and food products, entertainment, telecommunications and automotive, accessories, and equipment industries. As of December 31, 2015, it owned and operated approximately 650,000 advertising displays. The company was formerly known as Eller Media Company and changed its name to Clear Channel Outdoor Holdings, Inc. in August 2005. Clear Channel Outdoor Holdings, Inc. was incorporated in 1995 and is headquartered in San Antonio, Texas. Clear Channel Outdoor Holdings, Inc. is a subsidiary of iHeartCommunications, Inc.
